FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106478 [Registered on: 18/03/2026] Trial Registered Prospectively
Last Modified On: 18/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   A Study to Explore the Relationship Between Fingerprint Patterns and the Occurrence of Arsha 
Scientific Title of Study   Exploratory Study To Evaluate The Association Of Dermatoglyphic Patterns And Occurrence Of Arsha- An Observational, Analytical, Prospective Case Control Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sharmistha 
Designation  Pg Scholar 
Affiliation  Parul Institute of Ayurved And Research 
Address  Parul Institute of AYURVED and Research Parul university Vadodara GUJRAT 391760 India

Vadodara
GUJARAT
391760
India 
Phone  8840296078  
Fax    
Email  rajputishita1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bhagawan G Kulkarni 
Designation  Professor and Principal 
Affiliation  Parul Institute of Ayurved And Research 
Address  Parul Institute of AYURVED and Research Parul university Vadodara GUJRAT 391760 India

Vadodara
GUJARAT
391760
India 
Phone  9480302935  
Fax    
Email  drbgkulkarni@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhagawan G Kulkarni 
Designation  Professor and Principal 
Affiliation  Parul Institute of Ayurved And Research 
Address  Parul Institute of AYURVED and Research Parul university Vadodara GUJRAT 391760 India

Vadodara
GUJARAT
391760
India 
Phone  8840296078  
Fax    
Email  drbgkulkarni@gmail.com  
 
Source of Monetary or Material Support  
Khemdas Hospital  
 
Primary Sponsor  
Name  Dr Sharmistha 
Address  Parul Institute of Ayurved and Research Parul university Vadodra Gujrat 391760 India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sharmistha  Khemdas Hospital  OPD no 2, Ground floor,Parul Institute of Ayurved and Research, Parul University, Vadodara Gujarat 391760 India
Vadodara
GUJARAT 
08840296078

rajputishita1995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-PIARHR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  HAVING H/0 ARSHAS 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  case and control group willing to participate with informed consent, case report form and fingerprint assessment criteria sheet of fingerprint collection 
 
ExclusionCriteria 
Details  1 Diseases of hand like keratosis Palmaris Impetigo Burns Warts Leprosy and
many other skin diseases
2 Injuries and scars of palms
3 Systemic disorder which affecting connective tissue and vascular system
4 Individuals are with partial and complete amputations of upper limb finger and
hands both right and left 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Statistical association between dermatoglyphics patterns and the occurrence of
Arsha, as compared to matched healthy controls. 
18 months 
 
Secondary Outcome  
Outcome  TimePoints 
Identification of specific dermatoglyphic markers
1 Correlation of dermatoglyphics with Arsha
2 Assesssment of dermatoglyphic variations according to age & gender
3 Differences in ridge count & ATD,DAT,ADT angles on palm & fingers between
Arsha patient & controls
4 Generation of normative dermatoglyphics data for Arsha & control group for
future reference  
Baseline 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  06/04/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study titled Exploratory Study to Evaluate the Association of Dermatoglyphic Patterns and Occurrence of Arsha is an observational analytical prospective case control study designed to investigate the relationship between fingerprint patterns and the occurrence of Arsha hemorrhoids Dermatoglyphic patterns are genetically determined and remain constant throughout life therefore they may indicate genetic susceptibility to certain diseases The study will include 90 participants aged 20 to 60 years with 45 patients diagnosed with Arsha as the case group and 45 healthy individuals as the control group Fingerprints of all ten digits will be collected and analyzed for patterns such as loops whorls and arches and the findings will be compared between both groups The study will be conducted at Khemdas Hospital PIAR Parul Institute of Ayurved and Research following AYUSH Good Clinical Practice guidelines with informed consent from all participants The study aims to identify possible dermatoglyphic patterns associated with Arsha which may help in understanding genetic predisposition and early risk identification 
Close